Moreover, NKG2C+ NK cells have been associated with a lower viral setpoint in HIV infection9–11 and with a reduced relapse risk in leukemia patients who have undergone hematopoietic stem cell transplantation12, pointing towards strong anti-viral and anti-tumor activity of NKG2C+ NK cells. The gene discussed is KLRC2; the disease is leukemia.